Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Zifeng Yang and Yuqi Xie.
Zifeng Yang
Connection Strength
0.899
Yuqi Xie
  1. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2. J Ethnopharmacol. 2021 Oct 28; 279:114367.
    View in: PubMed
    Score: 0.238
  2. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-?B) signaling pathway. Phytomedicine. 2020 Nov; 78:153296.
    View in: PubMed
    Score: 0.224
  3. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-?B signaling pathway. Pharmacol Res. 2020 08; 158:104850.
    View in: PubMed
    Score: 0.220
  4. Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions. J Thorac Dis. 2020 Mar; 12(3):165-174.
    View in: PubMed
    Score: 0.217
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.